Lower levels of PAI-2 may contribute to impaired healing in venous ulcers — a preliminary study

Vascular

Volumn 8, Issue 5, 2000, Pages 381-385

  Stacey, Michael C ^a   Mata, Sandy D ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

plasminogen activator inhibitor 2; plasminogen activators; venous insufficiency; venous ulcers; wound healing

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; TISSUE HOMOGENATE; ULCER; ULCER HEALING; WOUND; WOUND HEALING;

AGED; AGED, 80 AND OVER; CHRONIC DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 2; TISSUE PLASMINOGEN ACTIVATOR; URINARY PLASMINOGEN ACTIVATOR; VARICOSE ULCER; WOUND HEALING;

EID: 0034253917     PISSN: 17085381     EISSN: None     Source Type: Journal    
DOI: 10.1177/096721090000800510     Document Type: Article

References (19)

1. Hippocrates. De ulceribus and De carnibus. In The Genuine Works of Hippocrates, ed. Adams E. F., Sydenham Society, London, 1849.
2. Adair H.M., Epidermal repair in chronic venous ulcers. British Journal of Surgery, 1977, 64, 800–804.
3. Browse N.L., Burnand K.G., The cause of venous ulceration. Lancet, 1983, ii, 243–245.
4. Thomas P., Nash G., Dormandy D., White cell accummulation in dependent leg of patients with venous hypertension: A possible mechanism for trophic changes in the skin. British Medical Journal, 1988, 296, 1693–1695.
5. Falanga V., Eaglstein W., The “trap” hypothesis of venous ulceration. Lancet, 1993, 341, 1006–1007.
6. Burnand K.G., Whimster I., Naidoo A., Browse N.L., Pericapillary fibrin in the ulcer bearing skin of the leg: The cause of lipodermatosclerosis and venous ulceration. British Medical Journal, 1982, 285, 1071–1072.
7. Stacey M.C., Burnand K.G., Bhogal B., Pattison M., Preclinical changes of lipodermatosclerosis in normal limbs. British Journal of Surgery, 1998, 75, 391.
8. Falanga V., Moosa H.H., Nemeth A.J., Alstadt S.P., Eaglstein W.H., Dermal pericapillary fibrin in venous disease and venous ulceration. Archives of Dermatology, 1987, 123, 620–623.
9. Browse N.L., Gray L., Jarrett P.E.M., Morland M., Blood and vein-wall fibrinolytic activity in health and vascular disease. British Medical Journal, 1977, 1, 478–481.
10. Stacey M.C., Burnand K.G., Mahmoud-Alexandroni M., Gaffney P.F., Bhogal B.S., Tissue and urokinase plasminogen activitors in the environs of venous and ischaemic leg ulcers. British Journal Surgery, 1993, 80, 596–599.
11. Baker M.S., Bleakley P., Woodrow G.C., Doe W.F., Inhibition of cancer cell urokinase plasminogen activator by its specific inhibitor PAI-2 and subsequent effects on extracellular matrix degradation. Cancer Research, 1990, 50, 4676–4684.
12. Yao J.S.T., Haemodynamic studies in peripheral disease. British Journal of Surgery, 1970, 57, 761–766.
13. Baker S.R., Stacey M.C., Jopp-McKay, A.G., Hoskin, S.E. and Thompson, P.J., Epidemiology of chronic venous ulcers. British Journal of Surgery, 1991, 78, 864–867.
14. Partsch H., Treatment of resistant leg ulcers by retrograde intravenous pressure infusions of urokinase. Phlebology, 1991, 6, 121–131.
15. Ehrly A. M., Schenk J., Bromberger U. Effects of low dose, long term urokinase on tcpO2 of patients with venous leg ulcers. In Phlebologie, eds Davey A., Stemmer R., John Libbey Eurotext, London, 1989, pp. 147–149.
16. Ellis V., Wun T.-C., Behrendt N., Ronne E., Dano K., Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors. Journal of Biological Chemistry, 1990, 265, 9904–9908.
17. Grondahl-Hansen J., Lund L.R., Ralfkiaer E., Ottevanger V., Dano K., Urokinase- and tissue-type plasminogen activators in keratinocytes during wound reepithelialisation in vivo. Journal of Investigations in Dermatology, 1988, 90, 790–795.
18. Cubellis M.V., Wun T.C., Blasi F., Receptor-mediated internalisation and degradation of urokinase is caused by its specific inhibitor PAI-1. EMBO Journal, 1990, 9, 1079–1085.
19. Estreicher A., Muhlhauser J., Carpentier J.-L., Orci L., Vassalli J.-D., The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes. Journal of Cellular Biology, 1990, 111, 783–792.